Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nociceptors are specialized peripheral sensory neurons that detect and transmit information about potentially damaging stimuli (mechanical, thermal, or chemical) to the central nervous system, resulting in the perception of pain. They are not a single molecule or receptor, but a class of neurons characterized by the expression of certain ion channels, G-protein-coupled receptors, and neuropeptides that enable them to sense noxious stimuli and participate in processes such as neurogenic inflammation and pain transmission. Various drugs target the channels and receptors expressed by nociceptors to modulate pain. Summary: There is no unique "Peripheral nociceptor receptor"—this is an imprecise and incorrect designation for a therapeutic target. Nociceptors are classified as pain-sensing neurons, not a receptor, but they express a wide variety of molecular targets that are the focus of pain drug development.
Blockade or desensitization of ion channels (TRP channels, sodium channels); Inhibition of neurotransmitter release (e.g., opioids decrease substance P release); Reduction of sensitization and neurogenic inflammation
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nociceptor (Peripheral nociceptor).